Michelle M. Mielke

Defining imaging biomarker cut points for brain aging and Alzheimer's disease

Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand et al. · Alzheimer s & Dementia · 2016 · 970 citations · Full text

Medicine, Neuroscience, Nuclear Medicine +17

Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

Michelle M. Mielke, Clinton E. Hagen, Jing Xu et al. · Alzheimer s & Dementia · 2018 · 662 citations

Medicine, Neurology, Neuroscience +16

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

Ganesh M. Babulal, Yakeel T. Quiroz, Benedict C. Albensi et al. · Alzheimer s & Dementia · 2018 · 539 citations · Full text

Medicine, Geriatric Medicine, Neurology +16

Performance of plasma phosphorylated tau 181 and 217 in the community

Michelle M. Mielke, Jeffrey L. Dage, Ryan D. Frank et al. · Nature Medicine · 2022 · 491 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +7

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

Rosebud O. Roberts, David S. Knopman, Michelle M. Mielke et al. · Neurology · 2013 · 487 citations

Medicine, Geriatric Medicine, Neurology +17